Cryoablation is a technique for the treatment of fibroadenomas. The modality involves the percutaneous insertion under ultrasound guidance of a cryoprobe, which destroys the lesion by means of a freeze-thaw-freeze cycle lasting about 20 minutes. IT si a low risk procedures adn The American Society of Breast Surgeons recommends the following criteria to establish a
patient as a potential candidate for cryoablation or percutaneous excision of a
fibroadenoma:
1. The lesion must be sonographically visible
2. The diagnosis of fibroadenoma must be confirmed histologically.
3. Lesions should be less than 4 cm in largest diameter
Simmons R, Ballman K, Cox C, et al: A phase II trial exploring the success of cryoablation therapy in the treatment of invasive breast carcinoma: Results from ACOSOG (Alliance) Z1072. American Society of Breast Surgeons Annual Meeting. Presented April 30, 2014.
Kaufman, CS, Littrup, PJ, Freeman-Gibb, et al., Office-Based Cryoablation of Breast Fibroadenomas: 12-Month Follow-up, Journal of the American College of Surgeons, 2004,
198 (6), 914-923.
https://www.breastsurgeons.org/new_layout/about/statements/PDF_Statements/Fibroadenoma.pdf, Accessed 9/12/17